5Mazzola C, Lissoni F, Scarpazza P, et al. The antihypertensive effects of benazepril,a nonfulphydryl angiotensin-converting enzyme inhibitor,in patients with essential hypertension,Curr Ther Res,1989,46(4):74.
6Whalen JJ. Definition of the effective dose of the converting enzyme inhibitor benazepril. Am Heart J, 1989,117:728.
7Cuyene TT, Belier M, Sassno P, et al. Crossover design for the doze determination of angiotensin converting enzyme inhibitor hypertension. J Hypertens, 1989,7:1005.
8Giuseppe M, Daniele A,Gerard J, et al, Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronicrenal insufficiency. N Engl J Med, 1996,334:943.
9Friedrich SP, Lorell BH, Rousseau MF, et al. Intraeardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation, 1994,90(6):2761.
10Haber HL, Powers ER, Gimpile LW, et M. Intracoronary angiotensin-converting enzyme inhibition improves diastolic funtion in patlentswith hypertension left ventricular hypertrophy.Circulation, 1994 ,89(6):2616.
1Bakris GL,Sarafidis PA,Weir MR,et al.Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events(ACCOMPLISH):a prespecitied secondary analysis of a randomised controlled trial[J].Lancet,2010,375(9721):1173-1181.
2Rubio-Guerra AF,Vargas-Robles H,Serrano AM,et al.Correlation Between the Levels of Circulating Adhesion Molecules and Atherosclerosis in Hypertensive Type-2 Diabetic Patients[J].Clin Exp Hypertens,2010,32(5):308-310.
3Ariyarajah V,Dawe D E,Khadem A.Is there a role for statins in at-rial fibrillation[J].Pacing Clin Electrophysiol,2009,32(81):63-72.
4Balakumar P,Kathuria S,Taneja G,et al.Is targeting e NOS a keymechanistic insight of cardiovascular defensive potentials of statins[J].J Mol Cell Cardiol,2011,13(9):24.
